ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 209 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $131,966 | -18.4% | 24,214 | +0.4% | 0.00% | – |
Q2 2023 | $161,784 | -20.5% | 24,111 | +4.6% | 0.00% | -100.0% |
Q1 2023 | $203,540 | +1.8% | 23,051 | -11.9% | 0.00% | 0.0% |
Q4 2022 | $199,969 | +15.6% | 26,174 | +7.7% | 0.00% | 0.0% |
Q3 2022 | $173,000 | -9.9% | 24,310 | +3.0% | 0.00% | 0.0% |
Q2 2022 | $192,000 | -5.4% | 23,601 | +61.3% | 0.00% | – |
Q1 2022 | $203,000 | -63.6% | 14,635 | -26.4% | 0.00% | -100.0% |
Q4 2021 | $558,000 | -45.4% | 19,874 | -33.9% | 0.00% | -66.7% |
Q3 2021 | $1,022,000 | -0.8% | 30,070 | +19.3% | 0.00% | 0.0% |
Q2 2021 | $1,030,000 | +32.9% | 25,211 | +30.9% | 0.00% | +50.0% |
Q1 2021 | $775,000 | -37.9% | 19,256 | -8.8% | 0.00% | -60.0% |
Q4 2020 | $1,248,000 | +17.3% | 21,107 | -3.5% | 0.01% | 0.0% |
Q3 2020 | $1,064,000 | +8.5% | 21,883 | +7.9% | 0.01% | 0.0% |
Q2 2020 | $981,000 | +106.1% | 20,274 | +18.3% | 0.01% | +66.7% |
Q1 2020 | $476,000 | -40.8% | 17,137 | -36.3% | 0.00% | -25.0% |
Q4 2019 | $804,000 | – | 26,888 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Matrix Capital Management Company, LP | 15,115,090 | $419,897,000 | 10.74% |
TIGER MANAGEMENT L.L.C. | 1,115,411 | $30,986,000 | 10.41% |
Robertson Stephens Wealth Management, LLC | 537,095 | $14,920,000 | 5.10% |
VIKING GLOBAL INVESTORS LP | 33,493,708 | $930,455,000 | 4.84% |
Senator Investment Group LP | 3,388,085 | $94,121,000 | 3.41% |
Casdin Capital, LLC | 793,125 | $22,033,000 | 2.34% |
Iron Triangle Partners LP | 150,000 | $4,167,000 | 1.61% |
Aristotle Atlantic Partners, LLC | 370,841 | $10,302,000 | 1.57% |
Crewe Advisors LLC | 93,000 | $2,584,000 | 1.54% |
PERSONAL CFO SOLUTIONS, LLC | 112,916 | $3,137,000 | 1.13% |